BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 34987650)

  • 1. Sonobiopsy for minimally invasive, spatiotemporally-controlled, and sensitive detection of glioblastoma-derived circulating tumor DNA.
    Pacia CP; Yuan J; Yue Y; Xu L; Nazeri A; Desai R; Gach HM; Wang X; Talcott MR; Chaudhuri AA; Dunn GP; Leuthardt EC; Chen H
    Theranostics; 2022; 12(1):362-378. PubMed ID: 34987650
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of the Targeting Accuracy of a Neuronavigation-Guided Transcranial FUS System In Vitro, In Vivo, and In Silico.
    Xu L; Pacia CP; Gong Y; Hu Z; Chien CY; Yang L; Gach HM; Hao Y; Comron H; Huang J; Leuthardt EC; Chen H
    IEEE Trans Biomed Eng; 2023 May; 70(5):1528-1538. PubMed ID: 36374883
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Focused ultrasound for safe and effective release of brain tumor biomarkers into the peripheral circulation.
    Zhu L; Nazeri A; Pacia CP; Yue Y; Chen H
    PLoS One; 2020; 15(6):e0234182. PubMed ID: 32492056
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Feasibility and safety of focused ultrasound-enabled liquid biopsy in the brain of a porcine model.
    Pacia CP; Zhu L; Yang Y; Yue Y; Nazeri A; Michael Gach H; Talcott MR; Leuthardt EC; Chen H
    Sci Rep; 2020 May; 10(1):7449. PubMed ID: 32366915
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Focused Ultrasound-mediated Liquid Biopsy in a Tauopathy Mouse Model.
    Pacia CP; Yuan J; Yue Y; Leuthardt EC; Benzinger TLS; Nazeri A; Chen H
    Radiology; 2023 Apr; 307(2):e220869. PubMed ID: 36719290
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Focused Ultrasound-Mediated Blood-Brain Barrier Opening Increases Delivery and Efficacy of Etoposide for Glioblastoma Treatment.
    Wei HJ; Upadhyayula PS; Pouliopoulos AN; Englander ZK; Zhang X; Jan CI; Guo J; Mela A; Zhang Z; Wang TJC; Bruce JN; Canoll PD; Feldstein NA; Zacharoulis S; Konofagou EE; Wu CC
    Int J Radiat Oncol Biol Phys; 2021 Jun; 110(2):539-550. PubMed ID: 33346092
    [TBL] [Abstract][Full Text] [Related]  

  • 7. First-in-human prospective trial of sonobiopsy in high-grade glioma patients using neuronavigation-guided focused ultrasound.
    Yuan J; Xu L; Chien CY; Yang Y; Yue Y; Fadera S; Stark AH; Schwetye KE; Nazeri A; Desai R; Athiraman U; Chaudhuri AA; Chen H; Leuthardt EC
    NPJ Precis Oncol; 2023 Sep; 7(1):92. PubMed ID: 37717084
    [TBL] [Abstract][Full Text] [Related]  

  • 8. First-in-human prospective trial of sonobiopsy in glioblastoma patients using neuronavigation-guided focused ultrasound.
    Yuan J; Xu L; Chien CY; Yang Y; Yue Y; Fadera S; Stark AH; Schwetye KE; Nazeri A; Desai R; Athiraman U; Chaudhuri AA; Chen H; Leuthardt EC
    medRxiv; 2023 Mar; ():. PubMed ID: 36993173
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating biomarkers in patients with glioblastoma.
    Müller Bark J; Kulasinghe A; Chua B; Day BW; Punyadeera C
    Br J Cancer; 2020 Feb; 122(3):295-305. PubMed ID: 31666668
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prolonged survival upon ultrasound-enhanced doxorubicin delivery in two syngenic glioblastoma mouse models.
    Kovacs Z; Werner B; Rassi A; Sass JO; Martin-Fiori E; Bernasconi M
    J Control Release; 2014 Aug; 187():74-82. PubMed ID: 24878186
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Focused Ultrasound-enabled Brain Tumor Liquid Biopsy.
    Zhu L; Cheng G; Ye D; Nazeri A; Yue Y; Liu W; Wang X; Dunn GP; Petti AA; Leuthardt EC; Chen H
    Sci Rep; 2018 Apr; 8(1):6553. PubMed ID: 29700310
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetic analysis of 111 in-labeled liposomal Doxorubicin in murine glioblastoma after blood-brain barrier disruption by focused ultrasound.
    Yang FY; Wang HE; Liu RS; Teng MC; Li JJ; Lu M; Wei MC; Wong TT
    PLoS One; 2012; 7(9):e45468. PubMed ID: 23029030
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Refining the delivery and therapeutic efficacy of cetuximab using focused ultrasound in a mouse model of glioblastoma: An
    Porret E; Kereselidze D; Dauba A; Schweitzer-Chaput A; Jegot B; Selingue E; Tournier N; Larrat B; Novell A; Truillet C
    Eur J Pharm Biopharm; 2023 Jan; 182():141-151. PubMed ID: 36529256
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ultrasound enhanced delivery of macromolecular agents in brain tumor rat model.
    Yang FY; Horng SC
    Annu Int Conf IEEE Eng Med Biol Soc; 2011; 2011():5573-6. PubMed ID: 22255602
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular diagnosis of diffuse glioma using a chip-based digital PCR system to analyze IDH, TERT, and H3 mutations in the cerebrospinal fluid.
    Fujioka Y; Hata N; Akagi Y; Kuga D; Hatae R; Sangatsuda Y; Michiwaki Y; Amemiya T; Takigawa K; Funakoshi Y; Sako A; Iwaki T; Iihara K; Mizoguchi M
    J Neurooncol; 2021 Mar; 152(1):47-54. PubMed ID: 33417137
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Self-Functionalized Superlattice Nanosensor Enables Glioblastoma Diagnosis Using Liquid Biopsy.
    Premachandran S; Haldavnekar R; Ganesh S; Das S; Venkatakrishnan K; Tan B
    ACS Nano; 2023 Oct; 17(20):19832-19852. PubMed ID: 37824714
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nanoparticle-Based Combinational Strategies for Overcoming the Blood-Brain Barrier and Blood-Tumor Barrier.
    Lim SH; Yee GT; Khang D
    Int J Nanomedicine; 2024; 19():2529-2552. PubMed ID: 38505170
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MR-guided focused ultrasound liquid biopsy enriches circulating biomarkers in patients with brain tumors.
    Meng Y; Pople CB; Suppiah S; Llinas M; Huang Y; Sahgal A; Perry J; Keith J; Davidson B; Hamani C; Amemiya Y; Seth A; Leong H; Heyn CC; Aubert I; Hynynen K; Lipsman N
    Neuro Oncol; 2021 Oct; 23(10):1789-1797. PubMed ID: 33693781
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liquid biopsies for the diagnosis and surveillance of primary pediatric central nervous system tumors: a review for practicing neurosurgeons.
    Bounajem MT; Karsy M; Jensen RL
    Neurosurg Focus; 2020 Jan; 48(1):E8. PubMed ID: 31896088
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Temporary blood-brain barrier disruption by low intensity pulsed ultrasound increases carboplatin delivery and efficacy in preclinical models of glioblastoma.
    Dréan A; Lemaire N; Bouchoux G; Goldwirt L; Canney M; Goli L; Bouzidi A; Schmitt C; Guehennec J; Verreault M; Sanson M; Delattre JY; Mokhtari K; Sottilini F; Carpentier A; Idbaih A
    J Neurooncol; 2019 Aug; 144(1):33-41. PubMed ID: 31197598
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.